Alerts will be sent to your verified email
Verify Email
ZIMLAB
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Zim Laboratories Ltd is a leading healthcare solution provider specializing in New Drug Delivery Systems. They have developed innovative technologies and products in areas such as Pellets, Multiplets, Resinates, Herbals, and Diagnostics.
Zim Laboratories major competitors are Medicamen Biotech, Albert David, Venus Remedies, Jenburkt Pharma, Kilitch Drugs(India), Prevest Denpro, Brooks Laboratories.
Market Cap of Zim Laboratories is ₹565 Crs.
While the median market cap of its peers are ₹601 Crs.
Zim Laboratories seems to be less financially stable compared to its competitors.
Altman Z score of Zim Laboratories is 3.23 and is ranked 7 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Mar Jun Sep Dec | Mar Jun Dec | Mar Jun Sep Dec | Jun Sep Dec | ||||||||||||||
| Investor Presentation | May | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Dec | Dec | Feb | Jun Sep Dec | ||||||||||
| Conference Call | May | Mar Sep | Mar Jun Sep Dec | |||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
